netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.05  Expand sub section  Drugs for erectile dysfunction
07.04.05  Expand sub section  Alprostadil
Alprostadil intracavernous injection (Caverject)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 

Provider notes

  • NMUH:
    • Red List Medicine – Hospital Only Prescribing
  • RFL:
    • Restricted to Urology and Endocrinology consultants
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Inj 20 micrograms only
 
   
Alprostadil intracavernous injection (Viridal Duo)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to Urology and Endocrinology Consultants
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Alprostadil urethral stick (MUSE)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 

Provider notes

  • NMUH:

    • Red List Medicine – Hospital Only Prescribing Restricted to Consultants in Urology and Sexual Health (St. Ann's) use only.
  • RFL:
    • Restricted to Urology and Endocrinology Consultants
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary
 
   
07.04.05  Expand sub section  Phosphodiesterase type 5 inhibitors
07.04.05  Expand sub section  Papaverine and phentolamine
 ....
 Non Formulary Items
Alprostadil 3mg/g cream  (Vitaros)
(Erectile dysfunction)

View adult BNF View SPC online View childrens BNF
Non Formulary

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary